We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




New Surgical Sealing Biomaterial Could Eliminate Standard Methods of Suturing and Stapling

By HospiMedica International staff writers
Posted on 31 Mar 2023
Print article
Image: New robust thermosensitive bioadhesives can improve surgical sealing (Photo courtesy of Pexels)
Image: New robust thermosensitive bioadhesives can improve surgical sealing (Photo courtesy of Pexels)

For surgical wounds to be properly closed, the sealant material used must effectively seal on wet, slippery tissue surfaces that vary in shape and may involve tissue movement, such as an expanding lung, or have crumbly textures. The application and effectiveness of the sealant must also occur within a suitable timeframe for surgical procedures. Traditional methods such as suturing and stapling can be ineffective and time-consuming, leading to increased blood loss. Fibrin-based bioadhesive sealants are expensive, exhibit insufficient adhesion, and are susceptible to viral transmission. Although commercial gelatin-based wound dressings offer biocompatibility, low cost, and hemostatic effectiveness, they lack adhesive strength due to inherent brittleness. Previous efforts to improve adhesion through functionalization with catechol, a naturally occurring compound that can provide adhesive capabilities when bound to gelatin, have been made. However, the limited number of binding sites on the gelatin results in a low level of adhesion achievable through catechol functionalization.

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI, Los Angeles, CA, USA) have utilized innovative chemistry to create an injectable biomaterial that has considerably enhanced adhesive strength, stretchability, and toughness. This hydrogel, based on gelatin and modified chemically, has numerous appealing features, including fast gelation at room temperature and customizable levels of adhesion. This specially designed biomaterial is ideal as a surgical wound sealant due to its injectability and controllable adhesion, as well as its superior ability to stick to a range of tissue and organ surfaces.

The researchers utilized caffeic acid (CA), a naturally occurring compound found in coffee and olive oil, to enhance the tissue adhesion properties of gelatin. To achieve this, they first oxidized CA to create CA oligomers (CAO), which consist of a small number of repeating catechol units. By coupling these CA derivatives with gelatin, they were able to significantly improve the chemical binding of catechol groups and enhance their adhesive capabilities. As a result, the engineered bioadhesive sealant exhibits superior adhesive strength, stretchability, toughness, and injectability, and can rapidly gel at the wound site, while maintaining stable adhesion under physiological conditions.

In addition, the sealants were engineered to exhibit selective tissue adhesion. This is crucial for effective sealing, as there must be strong bonding between the sealant and tissue at the interface, while avoiding adhesion on the opposite face of the sealant that is exposed to bodily fluids. Validation tests conducted on wet collagen sheets, as well as burst pressure experiments to assess the limits of adhesive strength, confirmed the efficacy of the new sealant and contradicted previous reports suggesting adverse effects of oxidative chemistry.

The newly developed sealant was put to the test on pig lung, heart, and bladder wounds in laboratory experiments. Results showed that the sealant's adhesive strength was significantly greater than that of commercial gelatin-based sealants. Even after being scraped and twisted experimentally, the sealant remained firmly affixed to the tissue surface. The biocompatibility of the sealant was also confirmed through testing. The sealant exhibited drug loading and drug release capabilities and demonstrated potential for promoting antioxidant effects that can aid in wound healing. This versatile technique can be applied to other biomaterials to impart strong adhesion.

“Our team has utilized manipulative and strategic chemistry to significantly improve adhesive strength and versatility in biomaterials,” said Ali Khademhosseini, TIBI’s Director and CEO. “This creates exciting possibilities for more effective surgical wound management in the clinic.”

Related Links:
TIBI

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Vein Illuminator
VSI

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.